SUBSCRIBE
SUBSCRIBE
News   Drug Development

VIVUS, Inc. Says Obesity Drug Helps Diabetics

June 9, 2009 | 
1 min read
Bookmark and Share

Reuters -- Drug developer Vivus Inc (VVUS.O) said on Monday said that its experimental drug Qnexa was shown to improve blood sugar control through weight loss in obese patients with type 2 diabetes.

Clinical research Phase II
MORE ON THIS TOPIC
Abstract creative art collage, market declines in the stock market. The concept of collapse or bankruptcy.
Weight loss
Viking Crashes as Obesity Pill Delivers Over 12% Weight Loss
August 19, 2025
 · 
2 min read
 · 
Tristan Manalac
Hands in black and white dropping a collection of pills on a pink background
Manufacturing
Oral Wegovy’s Pending Approval Puts Spotlight on Viability of High-Dose Peptides
August 19, 2025
 · 
5 min read
 · 
Nick Paul Taylor
Poster sketch image artwork photo collage of body language finger showing gesture symbol thumb down dislike dissatisfied minus no opinion.
Sickle cell disease
Pfizer’s $5.4B GBT Bet Disappoints Again as Sickle Cell Therapy Fails in Phase III
August 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VII
Obesity
Eli Lilly Keeps Obesity Pipeline Fresh With $1.3B Superluminal Partnership
August 14, 2025
 · 
1 min read
 · 
Dan Samorodnitsky